Findings

What do systematic reviews say?

766 questions · 806 findings · 76 reviews · ENT

Sort:Best matchNewestHighest certainty Download CSV

No studies found 293 · 36.4%GRADE not reported 6 · 0.7%Very low 244 · 30.3%Low 170 · 21.1%Moderate 85 · 10.5%High 8 · 1%

Saline irrigation plus pharmacological treatment vs pharmacological treatment alone

Disease severity score (up to 4 weeks) · allergic rhinitis

1 finding from 1 review

Saline irrigation for allergic rhinitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Saline irrigation plus pharmacological treatment vs pharmacological treatment alone

Disease severity score (4 weeks to 6 months) · allergic rhinitis

1 finding from 1 review

Saline irrigation for allergic rhinitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Low‐dose adjuvant radiotherapy vs standard‐dose adjuvant radiotherapy

Overall survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery

The review found no eligible studies for this question.

1 finding from 1 review

De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐dose adjuvant radiotherapy vs standard‐dose adjuvant radiotherapy

Disease-free survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery

The review found no eligible studies for this question.

1 finding from 1 review

De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐dose adjuvant radiotherapy vs standard‐dose adjuvant radiotherapy

Swallowing ability · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery

The review found no eligible studies for this question.

1 finding from 1 review

De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low‐dose adjuvant radiotherapy vs standard‐dose adjuvant radiotherapy

Voice (Voice Handicap Index) · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery

The review found no eligible studies for this question.

1 finding from 1 review

De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard‐dose adjuvant radiotherapy alone vs adjuvant chemoradiotherapy

Overall survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery

The review found no eligible studies for this question.

1 finding from 1 review

De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard‐dose adjuvant radiotherapy alone vs adjuvant chemoradiotherapy

Disease-free survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery

The review found no eligible studies for this question.

1 finding from 1 review

De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard‐dose adjuvant radiotherapy alone vs adjuvant chemoradiotherapy

Swallowing ability · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery

The review found no eligible studies for this question.

1 finding from 1 review

De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard‐dose adjuvant radiotherapy alone vs adjuvant chemoradiotherapy

Voice (Voice Handicap Index) · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery

The review found no eligible studies for this question.

1 finding from 1 review

De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally… 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Betahistine vs placebo

Tinnitus loudness · patients with subjective idiopathic tinnitus

2 findings from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 81 participants
Very low
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 70 participants
Very low

Betahistine vs placebo

Other adverse effects (yes or no) · patients with subjective idiopathic tinnitus

2 findings from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 11 participants
Very low
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Moderate

Betahistine vs placebo (with concurrent medication)

Change in tinnitus loudness match (range 0 to 5) · patients with subjective idiopathic tinnitus

1 finding from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Moderate

Betahistine vs placebo (with concurrent medication)

Significant adverse events · patients with subjective idiopathic tinnitus

1 finding from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 59 participants
Low

Betahistine vs placebo (with concurrent medication)

Tinnitus symptom severity · patients with subjective idiopathic tinnitus

The review found no eligible studies for this question.

1 finding from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Betahistine vs placebo (with concurrent medication)

Depressive symptoms · patients with subjective idiopathic tinnitus

The review found no eligible studies for this question.

1 finding from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Betahistine vs placebo (with concurrent medication)

Symptoms of generalised anxiety · patients with subjective idiopathic tinnitus

The review found no eligible studies for this question.

1 finding from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Betahistine vs placebo (with concurrent medication)

Other adverse effects (yes or no) · patients with subjective idiopathic tinnitus

1 finding from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 59 participants
Moderate

Betahistine vs placebo

Change in tinnitus loudness measured by a visual analogue scale (range 0 to more than 10) · patients with subjective idiopathic tinnitus

1 finding from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 11 participants
Very low

Betahistine vs placebo

Significant adverse events · patients with subjective idiopathic tinnitus

2 findings from 1 review

Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 11 participants
Very low
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Moderate